Keishiro Aoyagi Selected Research

Paraffin

4/2013

Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keishiro Aoyagi Research Topics

Disease

22	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2002
10	Neoplasms (Cancer) 10/2020 - 01/2002
7	Neoplasm Metastasis (Metastasis) 12/2015 - 10/2004
2	Lymphatic Metastasis 08/2022 - 01/2012
2	Carcinoma (Carcinomatosis) 03/2013 - 01/2003
2	Ascites 09/2010 - 02/2007
1	Edema (Dropsy) 01/2024
1	Hemorrhage 08/2022
1	Postgastrectomy Syndromes 03/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2015
1	Small Cell Carcinoma 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 10/2014
1	Weight Loss (Weight Reduction) 01/2014
1	Hypoxia (Hypoxemia) 04/2013
1	Adenoma (Adenomas) 01/2013
1	Adenocarcinoma 01/2013
1	Brain Neoplasms (Brain Tumor) 10/2004
1	Familial primary gastric lymphoma 07/2002

Drug/Important Bio-Agent (IBA)

6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 01/2005
3	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 01/2002
3	Bevacizumab (Avastin)FDA Link 10/2014 - 09/2010
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2014
2	Messenger RNA (mRNA)IBA 08/2022 - 01/2014
2	Monoclonal AntibodiesIBA 11/2013 - 09/2010
2	Indicators and Reagents (Reagents)IBA 04/2013 - 01/2005
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2003 - 07/2002
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2003 - 01/2002
1	Keratin-20 (Cytokeratin 20)IBA 08/2022
1	Cell Adhesion MoleculesIBA 08/2022
1	Carcinoembryonic AntigenIBA 08/2022
1	Adapalene (Differin)FDA LinkGeneric 07/2020
1	Taxoids (Taxanes)IBA 12/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2015
1	Docetaxel (Taxotere)FDA Link 12/2015
1	amrubicinIBA 12/2015
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2015
1	Etoposide (VP 16)FDA LinkGeneric 12/2015
1	human ERBB2 proteinIBA 10/2014
1	Cetuximab (Erbitux)FDA Link 10/2014
1	Trastuzumab (Herceptin)FDA Link 10/2014
1	Panitumumab (Vectibix)FDA Link 10/2014
1	RamucirumabIBA 10/2014
1	Vascular Endothelial Growth FactorsIBA 10/2014
1	EGF Family of ProteinsIBA 10/2014
1	N 30IBA 01/2014
1	GhrelinIBA 01/2014
1	EnzymesIBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Transcription Factors (Transcription Factor)IBA 04/2013
1	Oxygen (Dioxygen)IBA 04/2013
1	ParaffinIBA 04/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	Cyclin-Dependent Kinase Inhibitor p27IBA 03/2013
1	Interleukin-8 (Interleukin 8)IBA 01/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	Fibronectins (Fibronectin)IBA 01/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2007
1	Peroxidase (Myeloperoxidase)IBA 01/2005
1	AvidinIBA 01/2005
1	Biotin (Vitamin H)FDA Link 01/2005
1	doxifluridineIBA 10/2004
1	titanium silicide (TS-1)IBA 10/2004
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2003
1	RNA (Ribonucleic Acid)IBA 01/2003
1	deoxyuridine triphosphateIBA 07/2002
1	TransferasesIBA 07/2002
1	Amyloid (Amyloid Fibrils)IBA 01/2002
1	Fluorouracil (Carac)FDA LinkGeneric 01/2002

Therapy/Procedure

15	Gastrectomy 01/2024 - 02/2010
5	Therapeutics 12/2015 - 10/2004
1	Operative Time 01/2024
1	Gastroenterostomy 01/2024
1	Combined Modality Therapy 12/2015
1	Drug Therapy (Chemotherapy) 01/2014
1	Neoadjuvant Therapy 10/2013
1	Lymph Node Excision (Lymph Node Dissection) 01/2012
1	Operative Surgical Procedures 01/2012
1	Splenectomy 02/2010
1	Aftercare (After-Treatment) 01/2002